None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Those who voluntarily agree to participate in the clinical trial. 2. Healthy adults who are 19 and above. 3. Persons who are willing to comply with the clinical trial protocol. 4. Persons who agree to and are willing to visit during the follow up period. 5. Persons who have enlarged pores, wrinkles and pigmented lesions.
Exclusion criteria
Exclusion criteria: 1. Those who do not want to voluntarily participate or those who do are not willing to sign the agreement. 2. Those with facial infection, dermatitis, or rash. 3. Those with serious systemic disease or infection. 4.Those who are not able to participate in follow up or monitoring. 5. Any other person who, at the discretion of the examiner, judges of doctor. 6. Pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First effective evaluation of treatment (Pigmentation, pore and wrinkle evaluation on a 10-point VAS scale utilizing 3D camera and A-one spectrophotometer) | — |
Secondary
| Measure | Time frame |
|---|---|
| The area fraction of collagen fibers (Area fraction evaluated with Image J) | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center